1. Home
  2. APLT vs AWF Comparison

APLT vs AWF Comparison

Compare APLT & AWF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Therapeutics Inc.

APLT

Applied Therapeutics Inc.

HOLD

Current Price

$0.12

Market Cap

38.1M

Sector

Health Care

ML Signal

HOLD

Logo Alliancebernstein Global High Income Fund

AWF

Alliancebernstein Global High Income Fund

HOLD

Current Price

$10.67

Market Cap

924.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
APLT
AWF
Founded
2016
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
38.1M
924.4M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
APLT
AWF
Price
$0.12
$10.67
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$1.25
N/A
AVG Volume (30 Days)
9.3M
190.0K
Earning Date
11-13-2025
01-01-0001
Dividend Yield
N/A
7.57%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,000,000.00
N/A
Revenue This Year
$124.18
N/A
Revenue Next Year
$66.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$9.20
52 Week High
$1.50
$10.67

Technical Indicators

Market Signals
Indicator
APLT
AWF
Relative Strength Index (RSI) 26.58 40.42
Support Level $0.10 $10.53
Resistance Level $0.26 $10.71
Average True Range (ATR) 0.02 0.07
MACD 0.02 0.00
Stochastic Oscillator 15.57 25.20

Price Performance

Historical Comparison
APLT
AWF

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About AWF Alliancebernstein Global High Income Fund

Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.

Share on Social Networks: